By continuing, you agree to the Terms of Service.
This website uses cookies to enhance your browsing experience. Learn More.
Essential Cookies
Optional Cookies
Login
Logo for company ENDRA Life Sciences Inc.

ENDRA Life Sciences Inc. (NDRA)

NASDAQ Currency in USD
$313.00
-$2.86
-0.90%
Last Update: 18 Jul 2026, 12:54
$246.34m
Market Cap
-38.36
P/E Ratio (TTM)
Forward Dividend Yield
$219.40-$436.30
52 Week Range

NDRA Stock Price Chart

Explore ENDRA Life Sciences Inc. interactive price chart. Choose custom timeframes to analyze NDRA price movements and trends.

NDRA Company Profile

Discover essential business fundamentals and corporate details for ENDRA Life Sciences Inc. (NDRA) to support your stock research and investment decisions.

Sector

Healthcare

Industry

Medical - Diagnostics & Research

IPO Date

30 Jun 2017

Employees

21.00

CEO

Alexander Y. Tokman

Description

ENDRA Life Sciences Inc. specializes in advancing the capabilities of clinical diagnostic ultrasound. The company's primary development is thermo-acoustic enhanced ultrasound technology, which operates by emitting sound waves that echo off internal body components such as tissues, organs, and blood. This innovation is utilized in managing nonalcoholic fatty liver disease, meticulously monitoring temperature during thermoablative surgical procedures, detailed vascular imaging, and assessing tissue perfusion. Furthermore, ENDRA offers other diagnostic imaging modalities, including computed tomography (CT), magnetic resonance imaging (MRI), and conventional ultrasound. These instruments empower physicians to visualize internal anatomy, aiding in treatment guidance and the identification of various medical conditions like bone fractures, cancerous growths, indicators of heart disease, or internal bleeding. The company also maintains a research collaboration agreement with General Electric Company. Established in 2007, ENDRA Life Sciences Inc. is headquartered in Ann Arbor, Michigan.

NDRA Financial Timeline

Browse a chronological timeline of ENDRA Life Sciences Inc. corporate events including earnings releases, dividend announcements, and stock splits.

Upcoming earnings on 13 Aug 2026

EPS estimate is -$0.84, while revenue estimate is $100.00k.

Earnings released on 18 May 2026

EPS came in at -$1.09 surpassing the estimated -$1.23 by +11.38%.

Earnings released on 31 Mar 2026

EPS came in at -$3.26 falling short of the estimated -$1.23 by -165.04%.

Earnings released on 14 Nov 2025

EPS came in at -$1.75 surpassing the estimated -$1.95 by +10.26%.

Earnings released on 14 Aug 2025

EPS came in at -$1.71 surpassing the estimated -$2.27 by +24.67%.

Earnings released on 15 May 2025

EPS came in at -$2.59 surpassing the estimated -$3.91 by +33.76%.

Earnings released on 31 Mar 2025

EPS came in at -$9.40 falling short of the estimated -$4.10 by -129.27%, while revenue for the quarter reached $211.60k .

Earnings released on 15 Nov 2024

EPS came in at -$5.85 surpassing the estimated -$62.30 by +90.61%.

Stock split effective on 7 Nov 2024

Shares were split 1 : 35 , changing the number of shares outstanding and the price per share accordingly.

Earnings released on 22 Aug 2024

EPS came in at -$139.86 falling short of the estimated -$122.50 by -14.17%.

Stock split effective on 20 Aug 2024

Shares were split 1 : 50 , changing the number of shares outstanding and the price per share accordingly.

Earnings released on 14 May 2024

EPS came in at -$454.55 falling short of the estimated -$0.27 by -168.25k%.

Earnings released on 28 Mar 2024

EPS came in at -$297.20 falling short of the estimated -$0.36 by -82.46k%, while revenue for the quarter reached $428.41k .

Earnings released on 14 Nov 2023

EPS came in at -$699.30 falling short of the estimated -$0.43 by -162.53k%.

Earnings released on 14 Aug 2023

EPS came in at -$751.75 falling short of the estimated -$0.55 by -136.58k%.

Earnings released on 15 May 2023

EPS came in at -$1.63k surpassing the estimated -$1.78k by +8.82%.

Earnings released on 14 Mar 2023

EPS came in at -$1.82k falling short of the estimated -$1.40k by -30.00%.

Stock split effective on 9 Dec 2022

Shares were split 1 : 20 , changing the number of shares outstanding and the price per share accordingly.

Earnings released on 14 Nov 2022

EPS came in at -$1.75k surpassing the estimated -$2.10k by +16.67%.

Earnings released on 15 Aug 2022

EPS came in at -$2.10k falling short of the estimated -$1.75k by -20.00%.

Earnings released on 12 May 2022

EPS came in at -$2.45k matching the estimated -$2.45k.

Earnings released on 30 Mar 2022

EPS came in at -$2.45k falling short of the estimated -$1.60 by -152.87k%.

Earnings released on 15 Nov 2021

EPS came in at -$2.10k surpassing the estimated -$2.45k by +14.29%.

Earnings released on 12 Aug 2021

EPS came in at -$2.80k falling short of the estimated -$2.45k by -14.29%.

NDRA Stock Performance

Access detailed NDRA performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.

Explore Related Stocks

Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.

Discover More
Command Palette
Search for a command to run